Full approval would likely prompt the Centers for Medicare and Medicaid Services to change how it covers the drug, broadening access for up to about a million people with early onset Alzheimer’s.
Leqembi got accelerated approval in January, but it hasn’t been widely used because of an earlier coverage decision by the Centers for Medicare and Medicaid Services, which provides insurance for many elderly Alzheimer’s patients through Medicare.Centers for Medicare and Medicaid Services
said this year it would provide broader coverage for Leqembi if it receives traditional FDA approval. However, Medicare will only cover it when a physician and clinical team participate in the collection of evidence of real-world efficacy.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Goodbye child care centers, hello elderly homes: South Korea prepares for aging population | CNNThe number of child care facilities in South Korea has shrunk by almost a quarter in just a few years, reflecting authorities’ unsuccessful campaign to encourage couples to have more babies
続きを読む »
New Bill Would Require Medicare to Cover 'Home Resiliency' Amid Worsening Climate Crisis“Climate justice is a matter of disability justice,' said Sen. Ed Markey. 'It's time that we guarantee that seniors and people with disabilities can safely weather the climate crisis.'
続きを読む »
Senior-focused nonprofit awards $350,000 in grants to senior centers throughout San Diego CountyThe funding supports the hiring of staff, as well as new programs such as technology training, fitness classes and social activities
続きを読む »
Transplant group extends deadline that threatened flow of crucial organsThe nonprofit group that manages the complex national system for assigning organs to transplant patients has issued a two-week extension to a major company at risk of losing access to its database.
続きを読む »
FDA to decide on Alzheimer’s drug approvalFull approval would likely prompt the Centers for Medicare and Medicaid Services to change how it covers the drug, broadening access for up to about a million people with early onset Alzheimer’s.
続きを読む »
FDA to grant full approval for Alzheimer's medication LecanemabIf the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
続きを読む »